Dr. Gil Maldonado Manzanet, Csp - Medicare in Barceloneta, PR

Dr. Gil Maldonado Manzanet, Csp is a medicare enrolled "Clinic/center - Multi-specialty" provider in Barceloneta, Puerto Rico. Their current practice location is C67 Calle Georgetti, Urb Catalana, Barceloneta, Puerto Rico. You can reach out to their office (for appointments etc.) via phone at (787) 623-2526.

Dr. Gil Maldonado Manzanet, Csp is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Dr. Gil Maldonado Manzanet, Csp is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1235533365.

Contact Information

Dr. Gil Maldonado Manzanet, Csp
C67 Calle Georgetti, Urb Catalana,
Barceloneta, PR 00617
(787) 623-2526
Not Available



Healthcare Provider's Profile

Full NameDr. Gil Maldonado Manzanet, Csp
TypeFacility
SpecialityClinic/center - Multi-specialty
LocationC67 Calle Georgetti, Barceloneta, Puerto Rico
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1235533365
  • Provider Enumeration Date: 10/17/2014
  • Last Update Date: 05/05/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 5496168452
  • Enrollment ID: O20210112001107

Medical Identifiers

Medical identifiers for Dr. Gil Maldonado Manzanet, Csp such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1235533365NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
111N00000XChiropractor (* (Not Available))Secondary
133N00000XNutritionist (* (Not Available))Secondary
261QM1300XClinic/center - Multi-specialty (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Dr. Gil Maldonado Manzanet, Csp acts as a billing entity for following providers:
Provider NameGil Maldonado Manzanet
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1790915650
PECOS PAC ID: 7113064957
Enrollment ID: I20091027000469

News Archive

Yervoy approved for patients at high risk of developing recurrence of melanoma after surgery

Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.

Treating Sickle Cell Disease with L-Glutamine

By focusing on how best to help patients, researchers can sometimes find solutions that are much simpler than anticipated. That has been the guiding approach to our efforts to develop a treatment for sickle cell disease.

Study finds possible link between Type 2 diabetes and common white pigment

In a pilot study by a team of researchers at The University of Texas at Austin, crystalline particles of titanium dioxide - the most common white pigment in everyday products ranging from paint to candies - were found in pancreas specimens with Type 2 diabetes, suggesting that exposure to the white pigment is associated with the disease.

Three-pronged therapy triggers axons to regrow after spinal cord injury in rodents

Neuroscientists at UCLA, Harvard University and the Swiss Federal Institute of Technology have identified a three-pronged treatment that triggers axons – the tiny fibers that link our nerve cells and enable them to communicate – to regrow after complete spinal cord injury in rodents. Not only did the axons grow through scars, they could also transmit signals across the damaged tissue.

Read more Medical News

› Verified 7 days ago

Provider NameCamille Andrea Rivera Sandoval
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1720708522
PECOS PAC ID: 2860877404
Enrollment ID: I20220916002377

News Archive

Yervoy approved for patients at high risk of developing recurrence of melanoma after surgery

Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.

Treating Sickle Cell Disease with L-Glutamine

By focusing on how best to help patients, researchers can sometimes find solutions that are much simpler than anticipated. That has been the guiding approach to our efforts to develop a treatment for sickle cell disease.

Study finds possible link between Type 2 diabetes and common white pigment

In a pilot study by a team of researchers at The University of Texas at Austin, crystalline particles of titanium dioxide - the most common white pigment in everyday products ranging from paint to candies - were found in pancreas specimens with Type 2 diabetes, suggesting that exposure to the white pigment is associated with the disease.

Three-pronged therapy triggers axons to regrow after spinal cord injury in rodents

Neuroscientists at UCLA, Harvard University and the Swiss Federal Institute of Technology have identified a three-pronged treatment that triggers axons – the tiny fibers that link our nerve cells and enable them to communicate – to regrow after complete spinal cord injury in rodents. Not only did the axons grow through scars, they could also transmit signals across the damaged tissue.

Read more Medical News

› Verified 7 days ago

Provider NameNoelyz M Pagan Rivera
Provider TypePractitioner - Registered Dietitian Or Nutrition Professional
Provider IdentifiersNPI Number: 1033843495
PECOS PAC ID: 4789069063
Enrollment ID: I20220922002620

News Archive

Yervoy approved for patients at high risk of developing recurrence of melanoma after surgery

Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.

Treating Sickle Cell Disease with L-Glutamine

By focusing on how best to help patients, researchers can sometimes find solutions that are much simpler than anticipated. That has been the guiding approach to our efforts to develop a treatment for sickle cell disease.

Study finds possible link between Type 2 diabetes and common white pigment

In a pilot study by a team of researchers at The University of Texas at Austin, crystalline particles of titanium dioxide - the most common white pigment in everyday products ranging from paint to candies - were found in pancreas specimens with Type 2 diabetes, suggesting that exposure to the white pigment is associated with the disease.

Three-pronged therapy triggers axons to regrow after spinal cord injury in rodents

Neuroscientists at UCLA, Harvard University and the Swiss Federal Institute of Technology have identified a three-pronged treatment that triggers axons – the tiny fibers that link our nerve cells and enable them to communicate – to regrow after complete spinal cord injury in rodents. Not only did the axons grow through scars, they could also transmit signals across the damaged tissue.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr. Gil Maldonado Manzanet, Csp is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr. Gil Maldonado Manzanet, Csp
335 Calle Isla Verde, Urb Villas De La Playa,
Vega Baja, PR 00693

Ph: (787) 222-9263
Dr. Gil Maldonado Manzanet, Csp
C67 Calle Georgetti, Urb Catalana,
Barceloneta, PR 00617

Ph: (787) 623-2526

News Archive

Yervoy approved for patients at high risk of developing recurrence of melanoma after surgery

Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.

Treating Sickle Cell Disease with L-Glutamine

By focusing on how best to help patients, researchers can sometimes find solutions that are much simpler than anticipated. That has been the guiding approach to our efforts to develop a treatment for sickle cell disease.

Study finds possible link between Type 2 diabetes and common white pigment

In a pilot study by a team of researchers at The University of Texas at Austin, crystalline particles of titanium dioxide - the most common white pigment in everyday products ranging from paint to candies - were found in pancreas specimens with Type 2 diabetes, suggesting that exposure to the white pigment is associated with the disease.

Three-pronged therapy triggers axons to regrow after spinal cord injury in rodents

Neuroscientists at UCLA, Harvard University and the Swiss Federal Institute of Technology have identified a three-pronged treatment that triggers axons – the tiny fibers that link our nerve cells and enable them to communicate – to regrow after complete spinal cord injury in rodents. Not only did the axons grow through scars, they could also transmit signals across the damaged tissue.

Read more News

› Verified 7 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.